KV

Kelvinkumar Vallabhbhai Ladani

Active Director Director/Designated Partner DIN 11766076
DIN 11766076 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kelvinkumar Vallabhbhai Ladani

Kelvinkumar Vallabhbhai Ladani is a Director/Designated Partner at Zovian Pharmachem Llp (since 2026).

DIN 11766076
Primary Designation Director/Designated Partner
First Appointment 30 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director/Designated Partner30 Jun 20262026Active

Board colleagues of Kelvinkumar Vallabhbhai Ladani

NameDINCompanyDesignation
Bhargav Kishorbhai Dadhaniya11766077Zovian Pharmachem LlpDesignated Partner
Yogesh Soni11766078Zovian Pharmachem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Zovian Pharmachem Llp
Premium access

Shareholding and investment profile for Kelvinkumar Vallabhbhai Ladani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kelvinkumar Vallabhbhai Ladani

Kelvinkumar Vallabhbhai Ladani currently holds 1 directorship: Zovian Pharmachem Llp (Director/Designated Partner, since 30 Jun 2026).

Kelvinkumar Vallabhbhai Ladani was first appointed on 30 Jun 2026 as Director/Designated Partner at Zovian Pharmachem Llp.

The current boards of Kelvinkumar Vallabhbhai Ladani's companies include Bhargav Kishorbhai Dadhaniya (Zovian Pharmachem Llp), Yogesh Soni (Zovian Pharmachem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available